ClinicalTrials.gov
public full text
Public Domain
Tryptophan Metabolism in Kidney Disease
Tryptophan metabolism in kidney disease will be investigated in patients with chronic kidney disease stages (ADOQI 3-5). Tryptophan levels and respective catabolites will be assessed under hemodialysis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Association of Tryptophan Metabolites with Cognitive Impairment in Chronic Kidney Disease#294643
- A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function#881449
- New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients#839863
- Dysregulated Urea-synthesis at Terminal Uremia#906592
- Hemodialysis Frequency and the Calcification Propensity of Serum#226144
Record · ID 1074536
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive